Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance

Fig. 1

In vitro assessment of JMJD2A and cytoskeleton remodeling-related factors in CRPC docetaxel-resistant patients. A H&E staining to observe the pathological changes in clinical tissue samples; B PCR to detect the expression of miR-34a; C Immunohistochemistry to observe the content of microtubulin α-Tubulin and β-Tubulin, F-actin in clinical tissue samples; D Western Blot to detect the protein expression of JMJD2A, STMN1 and β3-Tubulin. ***P < 0.001, expression compared with the control group

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us